Skip to main content
. 2020 Mar 20;318(5):H1176–H1184. doi: 10.1152/ajpheart.00738.2019

Table 3.

Crossover study: secondary outcomes

SDn Tp-e, ms SDn Tp-e/QT SDn Tp-e/QTc
TC Smokers
    TC 1.16 ± 0.72 3.21 ± 2.02 2.43 ± 2.24
    Straw −0.49 ± 0.74 −1.29 ± 2.08 −1.90 ± 2.31
    P value 0.062 0.066 0.096
EC Users
    ECN 1.67 ± 0.46 5.06 ± 1.23 3.35 ± 1.08
    EC0 0.68 ± 0.45 2.58 ± 1.21 1.79 ± 1.06
    NI 0.12 ± 0.89 0.50 ± 2.36 0.61 ± 2.07
    Straw control 0.53 ± 0.44 1.23 ± 1.18 1.01 ± 1.04
    P value 0.83 0.70 0.88
Nonusers
    ECN 0.98 ± 0.35 2.78 ± 0.96 2.22 ± 0.86
    EC0 0.44 ± 0.35 0.98 ± 0.97 0.76 ± 0.87
    NI 0.19 ± 0.63 0.97 ± 1.74 1.58 ± 1.56
    Straw control 0.55 ± 0.44 1.52 ± 1.22 1.15 ± 1.10
    P value 0.78 0.71 0.76

Values are means ± SE and are adjusted for sex using a robust two-way analysis of variance model. EC, electronic cigarette; ECN, EC with nicotine; EC0, EC without nicotine; NI, nicotine inhaler; SDn, trimmed standard deviation; TC, tobacco cigarette; Tp-e, interval from T peak to T end.